Transcriptional modulation of β-Secretase ameliorates amyloid pathology and cognitive deficits in Alzheimer’s disease models
its pleiotropic pharmacology, CHX should be regarded here as a nonselective pharmacological probe rather than a repurposing-ready AD therapeutic. That said, the effect does not appear to be simply broad, nonspeci fi c suppression. Components of the γ -secretase complex were unchanged by CHX, and the reduction in gliosis...